The global malignant pleural effusion market is predicted to generate a market value of US$ 4.5 billion in 2023 and a market value of US$ 8.06 billion by 2033, with a CAGR of 6% from 2023 to 2033. The current market is driven by the rising incidence of pleural effusion disease and increased knowledge of advancements in pleural effusion treatment with various treatments. Between 2017 and 2022, the market for Malignant Pleural Effusion grew at a CAGR of 4%.
Growth of the Malignant Pleural Effusion market can be attributed to the rising burden of various diseases such as cancer and heart failure. The increasing burden of diseases in the United States is expected to create opportunities for the pleural effusions market. The data updated by the American Cancer Society’s Cancer Statistics 2022, nearly 1.9 million new cancer cases are estimated to be diagnosed in the United States in the year 2022.
In addition to this, the rising prevalence of pleural effusions has been contributing to the market growth. An article published by WebMD LLC in October 2021 stated that approximately 1.5 million pleural effusions are diagnosed in the United States every year and in industrialized countries, the estimated prevalence of pleural effusion is 320 cases per 100,000 people. Therefore, various factors such as awareness in wellness and health along with the research and development activities in the field like emerging novel therapeutics are increasing the efficacy of medicine as well as treatment.
Market Competition
Key players in the Malignant Pleural Effusion market are B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, and Smith Medical.
Browse More@ https://www.futuremarketinsights.com/reports/malignant-pleural-effusion-market
Key Segments Profiled in the Malignant Pleural Effusion Industry Survey
By Diagnosis:
- Imaging Tests
- Pleural Thoracentesis
- Pleural Fluid Cytology
- Immunohistochemical Tests
- Pleural Biopsy
- Thoracoscopy/Pleuroscopy
By End User:
- Hospitals
- Ambulatory Clinics
- Others
By Treatment:
- Systemic Therapy
- Therapeutic Thoracentesis
- Thoracic Drainage and Pleurodesis
- Indwelling Pleural Catheter
(Albany, US) DelveInsight has launched a new report on Epithelial Ovarian Cancer Market Insights, Epidemiology, and Market Forecast-2030.DelveInsight's " Epithelial Ovarian Cancer Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Epithelial Ovarian Cancer, historical and forecasted epidemiology as well as the Epithelial Ovarian Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.Some of Epithelial Ovarian Cancer Facts:The rate of new cases of ovarian cancer was 11.2 per 100,000 women per year.
This cancer mainly develops in older women.Request for Free Sample Report: https://www.delveinsight.com/sample-request/epithelial-ovarian-cancer-marketView Report: https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-marketScope of Epithelial Ovarian Cancer Report:The report covers the descriptive overview of Epithelial Ovarian Cancer, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapiesComprehensive insight has been provided into the Epithelial Ovarian Cancer epidemiology and treatment in the 7MMAdditionally, an all-inclusive account of both the current and emerging therapies for Epithelial Ovarian Cancer are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscapeA detailed review of Epithelial Ovarian Cancer market; historical and forecasted is included in the report, covering drug outreach in the 7MMThe report provides an edge while developing business strategies, by understanding trends shaping and driving the global Epithelial Ovarian Cancer marketRequest for Free Sample Report: https://www.delveinsight.com/sample-request/epithelial-ovarian-cancer-marketView Report: https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-marketOvarian cancer is a group of diseases that originates in the ovaries, or in the related areas of the fallopian tubes and the peritoneum.
In about 90 percent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60.The ovaries are mainly made up of 3 kinds of cells.
Each type of cell can develop into a different type of tumor: Epithelial tumors start from the cells that cover the outer surface of the ovary.
There are several types of benign epithelial tumors, including serous adenomas, mucinous adenomas, and Brenner tumors.
Studies have shown that epigenetic phenomenon may also play a role.
Global Thoracic Catheters Market Forecast to 2027The Global Thoracic Catheters Market report presents a comprehensive analysis of the Thoracic Catheters market by offering valuable insights to assist the businesses and key players in formulating fruitful strategies during the forecast timeline of 2020-2027.
The report studies the historical data to provide an assessment of key segments and sub-segments, revenue, industrial chain analysis, and demand and supply data.
The report also sheds light on the technological breakthroughs and product advancements happening in the Thoracic Catheters market.
According to the report, the Thoracic Catheters industry is likely to witness significant growth over the projected timeline.The report also covers the impact of the COVID-19 pandemic on the Thoracic Catheters market and major segments.
The pandemic has affected every industry vertical either positively or negatively.
The report also offers a thorough current and future analysis of the impact of the COVID-19 pandemic on the overall growth of the market.To get a sample PDF copy of the report Visit @ https://www.reportsanddata.com/sample-enquiry-form/6The report presents a panoramic view of the competitive landscape of the Thoracic Catheters market, covering details about the key manufacturers and companies, price analysis, revenue estimation, gross profit margins, business expansion plans, and other vital details that offers the readers deep insights into each company operating in the industry.
Global Thoracic Catheters Market Forecast to 2027The Global Thoracic Catheters Market report presents a comprehensive analysis of the Thoracic Catheters market by offering valuable insights to assist the businesses and key players in formulating fruitful strategies during the forecast timeline of 2020-2027.
The report studies the historical data to provide an assessment of key segments and sub-segments, revenue, industrial chain analysis, and demand and supply data.
The report also sheds light on the technological breakthroughs and product advancements happening in the Thoracic Catheters market.
According to the report, the Thoracic Catheters industry is likely to witness significant growth over the projected timeline.The report also covers the impact of the COVID-19 pandemic on the Thoracic Catheters market and major segments.
The pandemic has affected every industry vertical either positively or negatively.
The report also offers a thorough current and future analysis of the impact of the COVID-19 pandemic on the overall growth of the market.To get a sample PDF copy of the report Visit @https://www.reportsanddata.com/sample-enquiry-form/6The report presents a panoramic view of the competitive landscape of the Thoracic Catheters market, covering details about the key manufacturers and companies, price analysis, revenue estimation, gross profit margins, business expansion plans, and other vital details that offers the readers deep insights into each company operating in the industry.
According to the new market research report “Centesis Catheters Market by Type (Small and Large bore), Procedure (Paracentesis, Thoracentesis, Amniocentesis), Application (Diagnosis, Therapeutics and Palliative care), End user (Hospitals, Ambulatory surgery centers), Region – Global Forecast to 2025”, published by MarketsandMarkets™, the Centesis Catheters Market is projected to reach USD 633 million by 2025 from USD 426 million in 2019, at a CAGR of 6.8%.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=254850580Growth in the global centesis catheters market can be attributed to factors such as the rising target patient population (particularly patients suffering from cancer, TB, and cardiovascular diseases), growing preference for image-guided centesis procedures, and the increasing evidence for the efficacy of centesis procedures for target diseases.Small-bore centesis catheters segment accounted for the largest share of the centesis catheters market, by type, in 2018Based on type, the centesis catheters market is segmented into small-bore and large-bore centesis catheters.
The small-bore centesis catheters segment accounted for the largest share of this market in 2018.
This can be attributed to the wide availability of small-bore centesis catheters, growing number of target procedures that require small-bore centesis catheters, increasing evidence of the efficacy and safety of small-bore centesis catheters over large-bore centesis catheters, and their higher adoption in diagnostic centesis procedures.Browse in-depth TOC on “Centesis Catheters Market”118 – Tables30 – Figures155 – PagesParacentesis procedures segment accounted for the largest share of the centesis catheters market, by procedure, in 2018Based on procedure, the centesis catheters market is segmented into paracentesis, thoracentesis, arthrocentesis, amniocentesis, and other procedures.
The paracentesis segment accounted for the largest share of this market in 2018.
The rising incidence of target conditions such as gastrointestinal malignancies, liver cirrhosis, cystic fibrosis, intestinal tuberculosis, chronic liver failure, formation of cysts in the peritoneal cavity, and serious forms of hepatitis is expected to drive the growth of this market segment in the coming years.Hospitals were the largest end users of centesis catheters in 2018Based on end user, the global centesis catheters market has been segmented into hospitals, ambulatory surgical centers, and other end users.
The hospitals segment accounted for the largest share of the market in 2018.
